Should silodosin be taken with food or on an empty stomach?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Silodosin Administration with Food

Silodosin should be taken with a meal. This is the clear recommendation from the FDA drug label to reduce the risk of adverse events 1.

Rationale from FDA Drug Label

The FDA prescribing information explicitly states that patients should be instructed to take silodosin with a meal to reduce risk of adverse events 1. This recommendation is based on the fact that all safety and efficacy clinical trials for silodosin were conducted with food intake 1.

Pharmacokinetic Considerations

While food does affect silodosin absorption, the clinical impact is manageable:

  • Food decreases the maximum plasma concentration (Cmax) by approximately 18-43%
  • Food decreases overall drug exposure (AUC) by 4-49% across different studies
  • However, these reductions are not clinically significant enough to outweigh the safety benefits of taking the medication with food 1

The variable effect of food on absorption was studied with moderate fat, moderate calorie meals, and despite the reduction in peak levels, the drug maintains therapeutic efficacy when taken with food 1.

Clinical Practice Implications

Instruct patients to:

  • Take silodosin 8 mg once daily with any meal (breakfast, lunch, or dinner)
  • Maintain consistency in timing for optimal adherence
  • Not take on an empty stomach, as this increases the risk of adverse events, particularly orthostatic hypotension and dizziness

Important Safety Context

Taking silodosin with food is particularly important because:

  • The drug can cause postural hypotension and dizziness 1
  • Approximately one-third of patients in clinical studies used concomitant antihypertensive medications, which increases orthostatic risk 1
  • The incidence of dizziness and orthostatic hypotension was higher in patients on antihypertensives (4.6% vs 3.8% and 3.4% vs 3.2%, respectively) 1

This contrasts with some other medications (like certain sedative-hypnotics) where empty stomach administration is advised to maximize effectiveness 2, but for silodosin, the safety profile with food administration takes precedence 1.

References

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.